Mercury Fund led Topl's $3 million seed round. Photo via Getty Images

A Houston-based blockchain company that focuses on providing companies with ethical and sustainable practices within the supply chain has closed a $3 million round with support from investors both locally and across the country.

Today, Topl announced the closing of its seed round, which was led by Houston-based Mercury Fund with support from Houston-based GOOSE Capital, Chicago-based Chingona Ventures, Dallas-based RevTech Ventures, and New York-based firms Beni Venture Capital, Blue Collective, and Social Impact Capital.

"We're grateful to have closed an oversubscribed venture round during a pandemic, especially given the unfortunate truth that many women-led startups are getting much less investment during this time," says Kim Raath, CEO of Topl, in a press release. "Bringing transparency to causes dedicated to environmental and social good has never been more important. We are building a modern blockchain for a world where purpose and profit go hand in hand."

According to the release, Topl will use the fresh funds to speed up the launch of the company's blockchain-as-a-service solution for early next year.

Earlier this month, Topl announced a partnership with Denver-based TrackX, a software-as-a-service asset management and supply chain solution provider, aimed at combining technology to create a verifiable tracking and tracing solution to equip company supply chains with sustainability, transparency, and efficiency. Ultimately, it's Topl's goal to allow its users the ability to stand out to customers as sustainable and responsible brands — something that's become increasingly more important to consumers.

"A company's social and environmental impact has become a necessary point of differentiation for brands, and Topl has the potential to be the leading player for brands who are serious about [Environmental, Social, and Corporate Governance]," says Blair Garrou, managing director of Mercury Fund.

To date, Topl has raised $4.4 million in funding. It's first seed round closed September 2019. For that round, Samantha Lewis, formerly director of GOOSE Capital, was instrumental, according to the release.

"Kim and the Topl team have created a custom-designed method to measure and verify your company's sustainability efforts. We're excited to be part of this intersection of cutting-edge technology and positive impact," Lewis, who's now on the board of the startup, says in the release.

Topl's technology has the ability to affect any industry, and the company has worked with tracing products from diamonds and chocolate to natural resources and even COVID-19 testing.

"Topl's track-and-trace solution appeals to so many core industries: from healthcare to agriculture to energy," says Manolo Sánchez, former chairman and CEO of BBVA Compass and also a member of Topl's board, in the release. "Anyone who needs to ensure transparency, efficiency and sustainability would benefit from their technology."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.